IntegenX

About:

IntegenX designs, manufactures and markets automation systems facilitating reliable micro sample preparation and analysis.

Website: http://integenx.com

Twitter/X: IntegenX

Top Investors: Horizon Technology Finance, Western Technology Investment, Cross Creek, Domain Associates, In-Q-Tel

Description:

IntegenX, Inc. designs, manufactures, and markets automation systems that enable reliable microsample preparation and analysis for the life sciences. It offers Apollo 100, a platform that allows the processing of DNA sequencing reactions; Apollo 200, an integrated sample preparation system for human DNA identification; microfluidics for DNA sequencing, molecular diagnostics, and human identification applications; and Apollo 324 system, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing. The company was formerly known as Microchip Biotechnologies, Inc. and changed its name to IntegenX, Inc. in March 2010. The company was incorporated in 2003 and is based in Pleasanton, California.

Total Funding Amount:

$88.2M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Pleasanton, California, United States

Founded Date:

2006-01-01

Contact Email:

information(AT)integenx.com

Founders:

Dennis Harris, Stevan Jovanovich

Number of Employees:

101-250

Last Funding Date:

2014-09-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai